PENSACOLA, Fla., Oct. 10, 2019 /PRNewswire/ -- Intelligent Retinal Imaging Systems, Inc. (IRIS), the industry leader in telemedicine solutions for diabeti

BRONX, N.Y., Oct. 10, 2019 /PRNewswire/ -- Albert Einstein College of Medicine and the

SANTA CLARA, Calif., Oct. 10, 2019 /PRNewswire/ -- eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that the company plans to release third quarter 2019 financial results on October 24, 2019.Chief Executive Officer Scott Flanders and Chief Financial

SAN MARCOS, Calif., Oct. 10, 2019 /PRNewswire/ -- North County Health Services (NCHS) announced a strategic partnership with OCHIN to provide a comprehensive Electronic Health and Dental Record (EHR/EDR) system, practice management, and other solutions to serve its more than 67,000 patients in North San Diego County and

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in an exploratory Phase 2 clinical trial evaluating the ability of defibrotide to prevent neurotoxicity in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) receiving CAR T-cell therapy. The prospectiv

JACKSONVILLE, Fla., Oct. 10, 2019 /PRNewswire/ -- Healogics® Inc., the nation's largest provider of advanced chronic wound care services, celebrates the 100th enrollment in Healogics® iSupply during National Healthcare Supply Chain Week. The Healogics iSupply program is focused on ensuring hospitals and patients receive the best value from wound care p

SUNNYVALE, Calif., Oct. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/

MARINA DEL REY, Calif., Oct. 10, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it has expanded its Board of Directors with the appointment of Todd C. Peterso

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion recommending marketing authorization of Mirataz&

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced that the final patient was enrolled and randomized today in the company's phase 2 EMPhASIS trial of IMU-838 for t